x
Diapeutic Logo

80+

Years of Combined Experience
Our Mission

Restoring Skin Health Through Advanced Diagnostics

Our Mission is to enable the restoration of skin health. We do this through high-quality precision sampling and advanced molecular testing to objectively assess health-status and guide therapeutic and care decisions.

Patient Centric

We are focused on improving outcomes and delivering high quality value-based medicine.

Technology Experience

We leverage decades of experience in genomics, biotechnology, and skin biology to deliver advanced molecular diagnostics that inform critical therapeutic decisions.

Industry Access

From Research to Medicine we leverage long-standing academic and commercial relationships to facilitate market access, regulatory compliance, and operational scalability.

Clinical Excellence

Sample Quality Matters

The foundation of precision medicine is the quality of the tissue sample. By combining our advanced, minimally invasive sampling technology with precise molecular testing, Diapeutic Dx eliminates the ambiguity of traditional diagnostics. This synergy delivers profound benefits across the healthcare spectrum.

Patients Benefit

Better Care Decisions: Accurate molecular data enables highly personalized therapies. Patients avoid painful traditional biopsies and receive treatments explicitly tailored to their unique pathology, improving outcomes.

Providers Benefit

Clinical Objectivity: High-yield samples provide indisputable molecular documentation, removing visual guesswork. Furthermore, our devices facilitate highly reimbursable, efficient in-office procedures.

Payers Benefit

Paying for What Works: Definitive molecular diagnostics prevent wasteful spending on trial-and-error treatments. Payers achieve superior health-economic value by funding targeted, data-backed interventions.

Why Molecular Tests Matter

Subjective diagnosis leads to trial-and-error medicine. Molecular tests offer objective assessment and therapeutic decision making which improves outcomes and lowers costs.

$ 0 .6B

Global Skin Cancer Diagnostics Market

Projected 2024 TAM

Source: Grand View Research, 2024
$ 0 .9B

Global Chronic Wound Care Market

Projected 2024 TAM

Source: Zion Market Research, 2024
$ 0 .5B

Global Aesthetic Dermatology Market

Projected 2024 TAM

Source: Custom Market Insights, 2024
Our Strengths

Leaders in skin biology, medical devices,
and commercial execution.

Medical Community Access

World Class Innovative Research

Critical Intellectual Property

Decades of Commercial Experience